Latest news
{{'Tue, 21 Jul 2026 07:35:00 -0400' | dateFormatUsFilter}}
Novo Nordisk Takes Action to Stop Multiple Misleading National GLP-1 Advertising Campaigns by Eli Lilly
Read more
{{'Sat, 11 Jul 2026 08:05:00 -0400' | dateFormatUsFilter}}
Novo Nordisk's denecimig (Mim8) demonstrated positive results in long term safety and efficacy in phase 3 hemophilia A FRONTIER extension study at ISTH 2026
Read more
{{'Wed, 01 Jul 2026 07:00:00 -0400' | dateFormatUsFilter}}
Wegovy® is now accessible to eligible Medicare beneficiaries living with obesity through Medicare GLP-1 Bridge
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.